What does Heilongjiang ZBD Pharmaceutical Co., Ltd. do?

Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 603567.SS's market cap?

Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) has a market capitalization of approximately $5.52 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 603567.SS pay a dividend?

Yes — Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) pays a dividend annually, with a trailing-twelve-month yield of 2.56%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 603567.SS profitable?

Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥5.87¥0.20+3.53%

Market cap¥5.52B·Market closed·Aug 27 5:53 AM UTC

Price Chart

¥5.87+¥0.20 (+3.53%)today

−64.05%CAGR −18.51%

Select date range

FromTo

Apr 24, 2015Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)2.56%

Annual Dividend (FWD)¥0.15

Dividend Growth (5Y)−7.1%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio23.5%

Most Recent Dividend¥0.150

Ex-Dividend DateAug 20

Payment DateAug 20

EarningsEarnings Tab

EPS (FWD)¥0.80

P/E Ratio (FWD)7.34

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateOct 27

Last Report DateApr 29

Reported vs Estimate−¥1.06

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥510.28M

Net Income−¥1.62B

Net Margin−317.8%

Operating Cash Flow¥650.76M

Capital Expenditures¥50.58M

Free Cash Flow¥600.17M

Return on Equity−26.6%

Return on Invested Capital−0.8%

Net Debt¥1.98B

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603567.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603567.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603567.SS and 80,000+ other tickers.

About Heilongjiang ZBD Pharmaceutical Co., Ltd.

Heilongjiang ZBD Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the entire lifecycle of Traditional Chinese Medicine (TCM), from research and development to manufacturing and sales, exclusively within China. Its extensive product portfolio addresses a wide spectrum of health concerns, including conditions related to cardiovascular and cerebrovascular health, respiratory ailments, orthopedic issues, oncology, digestive disorders, anti-infective treatments, neuropsychiatric conditions, and genitourinary problems, among others. Established in 1996, the company maintains its headquarters in Hulin, China.

CEO: Jiujiang Yan
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 1,961
Website: www.zbdzy.com

Peers

Peers Tab

600129.SS

Chongqing Taiji Industry(Group) Co.,Ltd

Cap

¥8.0B

002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd.

Cap

¥8.4B

600812.SS

North China Pharmaceutical Company Ltd.

Cap

¥8.5B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603567.SS

What does Heilongjiang ZBD Pharmaceutical Co., Ltd. do?: Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603567.SS's market cap?: Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) has a market capitalization of approximately $5.52 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 603567.SS pay a dividend?: Yes — Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) pays a dividend annually, with a trailing-twelve-month yield of 2.56%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 603567.SS profitable?: Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.